CVS Health Corporation carries a market capitalization of 116.58B, placing it among publicly traded companies globally. Its enterprise value stands at 157.90B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 116.58B |
| Enterprise Value | 157.90B |
CVS Health Corporation currently has 1.27B shares outstanding.
| Shares Outstanding | 1.27B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
CVS Health Corporation trades at a trailing price-to-earnings ratio of 31.10. The price-to-sales ratio is 0.22, and the price-to-book ratio stands at 0.80.
| PE Ratio | 31.10 |
| PS Ratio | 0.22 |
| PB Ratio | 0.80 |
| P/TBV Ratio | -2.77 |
| P/FCF Ratio | 6.89 |
| P/OCF Ratio | 8.82 |
On an enterprise value basis, CVS Health Corporation trades at an EV/EBITDA multiple of 9.71 and an EV/FCF ratio of 9.94. The EV/Sales ratio of 0.39 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 13.51 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.39 |
| EV / EBITDA | 9.71 |
| EV / EBIT | 13.51 |
| EV / FCF | 9.94 |
CVS Health Corporation maintains a current ratio of 0.87, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 100.91, indicating elevated leverage, while an interest coverage ratio of 5.23 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 0.87 |
| Quick Ratio | 0.61 |
| Debt / Equity | 100.91 |
| Debt / EBITDA | 4.82 |
| Interest Coverage | 5.23 |
CVS Health Corporation posts a return on equity of 2.58 and a return on invested capital of 6.25.
| Return on Equity (ROE) | 2.58 |
| Return on Assets (ROA) | 1.15 |
| Return on Invested Capital (ROIC) | 6.25 |
| Return on Capital Employed (ROCE) | 2.88 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 19.99 |
Over the trailing twelve months, CVS Health Corporation has paid 554.00M in income taxes, reflecting an effective tax rate of 16.03.
| Income Tax | 554.00M |
| Effective Tax Rate | 16.03 |
CVS Health Corporation's stock has gained approximately 43.68611% over the past 52 weeks. The 50-day moving average sits at 82.75, while the 200-day moving average is 78.63.
| Beta (5Y) | N/A |
| 52-Week Price Change | 43.68611% |
| 50-Day Moving Average | 82.75 |
| 200-Day Moving Average | 78.63 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, CVS Health Corporation generated 407.91B in revenue and converted that into 2.93B in net income, yielding earnings per share of 2.28. EBITDA reached 16.26B, while operating income came in at 11.69B.
| Revenue | 407.91B |
| Gross Profit | 56.59B |
| Operating Income | 11.69B |
| Pretax Income | 3.46B |
| Net Income | 2.93B |
| EBITDA | 16.26B |
| EBIT | 11.69B |
| Earnings Per Share (EPS) | 2.28 |
CVS Health Corporation holds 11.80B in cash and equivalents against 78.35B in total debt, resulting in a net debt position of 53.57B. Total book value stands at 113.96B, with working capital of -11.59B providing operational flexibility.
| Cash & Cash Equivalents | 11.80B |
| Total Debt | 78.35B |
| Net Debt | 53.57B |
| Equity (Book Value) | 113.96B |
| Book Value Per Share | 89.77 |
| Working Capital | -11.59B |
CVS Health Corporation produced 10.33B in operating cash flow over the past twelve months. After subtracting -2.94B in capital expenditures, free cash flow totaled 7.39B - equivalent to 5.82 per share.
| Operating Cash Flow | 10.33B |
| Capital Expenditures | -2.94B |
| Free Cash Flow | 7.39B |
| FCF Per Share | 5.82 |
CVS Health Corporation operates with a gross margin of 13.87, reflecting its pricing power and cost economics. The operating margin of 2.87 and net profit margin of 0.72 provide insight into operational efficiency.
| Gross Margin | 13.87 |
| Operating Margin | 2.87 |
| Pretax Margin | 0.85 |
| Profit Margin | 0.72 |
| EBITDA Margin | 3.99 |
The company's payout ratio of 118.44 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 2.68 |
| Dividend Yield | N/A |
| Payout Ratio | 118.44 |
| Shareholder Yield | 5.40 |
| FCF Yield | 14.51 |
CVS Health Corporation's most recent stock split took place on June 7, 2005 with a 1:2 split ratio.
| Last Split Date | 6/7/2005 |
| Split Ratio | 1:2 |
CVS Health Corporation posts an Altman Z-Score of 3.97, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.97 |